Abs sbtract. Investigations ofpolymorphonuclear leukocyte (PMN) function were performed in a 5-yr-old white female with delayed umbilical cord separation, impaired pus formation, and a severe defect of PMN chemotaxis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated an almost total deficiency of a high molecular weight glycoprotein(s) (GP1 38) 
Introduction
The delineation of a molecular basis for cell dysfunction in a limited number of primary neutrophil disorders has allowed unique and important contributions to our understanding of leukocyte biology (1) . A clinical syndrome characterized by recurrent bacterial or fungal infection, progressive periodontitis, persistent leukocytosis, and/or delayed umbilical cord separation has been recently described in three children whose neutrophils demonstrated severely depressed adherence, chemotaxis, and phagocytic function, and a deficiency or absence ofa particulate fraction glycoprotein (2, 3) . Additionally, Amaout et al. (4) reported studies in a male child with recurrent bacterial infections and diminished phagocytosis associated with a deficient granulocyte membrane glycoprotein (GPI50). Further studies in that patient have demonstrated a severe deficiency of Mol (equivalent to OKM 1) and LFA 1, two functionally related high molecular weight glycoproteins normally expressed on the polymorphonuclear leukocyte (PMN) surface (5) .
Investigations described in this report have identified a total deficiency of PMN and monocyte Mol and LFA1 in a female patient with a similar clinical syndrome (6) . These studies were designed to explore the role of these glycoproteins in allowing normal PMNs to interact with experimental or biologic substrates, phagocytizable test particles, or the surfaces of other cell types, and to determine their topographical and/or functional relationships to selected PMN membrane receptors. Our findings provide new evidence that motile, phagocytic, and cytotoxic functions of PMN are linked to cell adhesive properties mediated by critical surface glycoproteins.
Methods
Isolation of PMN leukocytes. PMNs were purified from heparinized venous blood samples over Ficoll-Hypaque gradients and suspended in Dulbecco's phosphate-buffered saline (DPBS)1 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY), pH 7.4, containing 0.2% dextrose. Final PMN suspensions contained >97% PMNs, minimal platelet contamination, and an erythrocyte:PMN ratio of .3: 1. For use in chemiluminescence (CL), aggregometry, sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE), or N-formyl-methionylleucyl-3H-phenylalanine (f-Met-Leu-3H-Phe) binding studies, erythrocytes were eliminated by hypotonic lysis (7) .
Preparation of membrane and granule-rich fractions. As described previously (2) , PMNs (108) were placed in 2 ml of ice cold DPBS, 100
1. Abbreviations used in this paper: ACLB, albumin-coated latex bead; ADCC, antibody-dependent cellular cytotoxicity; C, complement; CF, chemotactic factor; CL, chemiluminescence; DPBS, Dulbecco's phosphate-buffered saline; E, sheep erythrocytes; f-Met-Leu-3H-Phe, N-formylmethionyl-leucyl-3H-phenylalanine; FITC, fluorescein isothiocyanate; HSA, human serum albumin; HSV, herpes simplex virus; IF, immunofluorescence; MT, microtubules; NP-40, nonidet P40; PAS, periodic acid-silver; PMA, phorbol myristate acetate; PMSF, phenylmethylsulfonylfluoride; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; ZAP, zymosan-activated plasma.
,d of diisopropylfluorophosphate (0.1 M in ethylene glycol) was added, and the mixture incubated at 4°C for 30 min. Cells were washed three times in DPBS, placed in 2 ml of an ice cold solution of 0.34 M sucrose and 3 mM phenylmethylsulfonylfluoride (PMSF), and then broken in a teflon homogenizer. Broken cells were subjected to a brief low speed spin (1000 g) for 10 min to remove nuclei, unbroken whole cells, and membrane aggregates, and the supernatant was then centrifuged at 27,000 g for 30 min. The supernatant from the 27,000 g centrifugation was then subjected to centrifugation at 105,000 g for I h.
Preparation of reagents. Stock solutions of f-Met-Leu-Phe (Sigma Chemical Co., St. Louis, MO) and f-Met-Leu-3H-Phe (New England Nuclear, Boston, MA) were prepared in DPBS. A low molecular weight chemotactic factor (CF), referred to as complement C5a in this manuscript, was prepared from activated human sera as described (8) . Neur- aminidase from Vibrio cholerae (500 units/ml) was purchased from Schwarz/Mann (Orangeburg, NY). Galactose oxidase from Dactylium dendroides (Sigma Chemical Co.) was further purified by affinity chromatography over Sepharose (9) . NaB3H4 was obtained from New England Nuclear. This material (sp act, 15 Ci/mmol; total, 250 mCi) was dissolved in 2.5 ml of 0.01 M NaOH. Zymosan, calcium ionophore A23187, cytochalasin B, colchicine, fluorescein isothiocyanate (FITC)-concanavalin A, nonidet P-40 (NP-40), phorbol myristate acetate (PMA) (Sigma Chemical Co.), and rabbit anti-human serum albumin (HSA) (Calbiochem-Behring Corp., La Jolla, CA) were obtained commercially. Antilactoferrin and Anti-tubulin IgG were prepared as previously described (10, 11) .
Monoclonal antibodies (Mab). The MAb to Mol was kindly provided by Dr. R. F. Todd III (12) . The OKM I MAb was obtained from Ortho Pharmaceutical (Raritan, NJ). The TSI/2 MAb to LFA I-a and the TS I/18 MAb to the common ,-subunit of LFA I and Mo l/OKM I were prepared as previously described (13) . F(ab')2 fragments of IgG2 antiMol were prepared by pepsin digestion (14). A F(ab')2& fragment of rabbit IgG directed against the human C3b receptor (anti-CR 1) was a generous gift of Dr. D. Fearon, Harvard Medical School, Boston, MA (15) . SDS-PAGE. SDS-PAGE was performed as described by Laemmli (16) using both 2.5 X 110-mm cylindrical gels or 5 X 120 X 140-mm slab gels. For whole cells preparations, 2 X 107 cells were treated with diisopropylfluorophosphate and solubilized in 0.2 ml of 1% NP-40 containing 2 mM PMSF (2). PMN granules or membranes were placed directly in SDS containing sample buffer. Cylindrical gels were stained with a 10% perchloric acid solution of Coomassie Blue G. Slab gels were stained with Coomassie Blue R-250 or silver. Periodic acid-silver (PAS) stains of carbohydrates were also performed (17) .
Surface labeling of PMN glycoproteins. PMNs (2 X 10') were simultaneously treated with 0.025 ml of neuraminidase (5 units) and 0.025 ml ofgalactose oxidase (12.5 units) in I ml of DPBS (18) . Although neuraminidase treatment can decrease resolution in subsequent SDS-PAGE, efficient labeling of the deficient surface glycoprotein requires this procedure. The cells were shaken gently on a 37°C water bath for 30 min and then washed twice and resuspended in 0.5 ml of phosphatebuffered saline (PBS). I mCi of NaB3H4 was added and the reaction was allowed to proceed for 30 min at 21 'C. Cells were collected by centrifugation and washed three times in DPBS. After solubilization of the cells in 1% NP-40 and removal of nuclei and cell material by low speed centrifugation, the supernatant (0.2 ml) was placed in SDS sample buffer, boiled for 2 min, and subjected to SDS-PAGE. After SDS-PAGE, the gels were either stained with Coomassie-Blue G or sectioned into 1.5-mm slices, and the radioactivity was determined in a scintillation counter (19, 20) .
Flow cytometry immunofluorescence studies. Indirect immunofluorescence of intact PMNs was performed using MAbs and fluoresceinconjugated antimouse IgG or antigoat IgG F(ab')2 as previously described (21, 22) . Surface-stained PMNs were fixed in 1% paraformaldehyde and processed in a Coulter Epics V flow cytometer (Coulter Electronics, Inc., Hialeah, FL).
Immunoprecipitation studies. Intact PMNs were "25I-surface labeled with lodogen (Pierce Chemical Co., Rockford, IL) as described (5) . After labeling, cells were solubilized in 0.5% NP-40 in PBS and the lysates centrifuged at 105,000 g for 30 min. Supernatants were precleared with immune complexes consisting of a control mouse MAb, rabbit IgG antimouse IgG, and heat-inactivated formalin fixed Staphylococcus aureus. Precleared lysates were then incubated for 12-16 h with the specific MAb. Rabbit antiserum to mouse Ig or a rat antimouse kappa chain MAb was added and incubation continued for 1 h at 4°C, followed by S. aureus (30 min, 4C). The insolubilized immune complexes were washed four times with PBS containing 2 mM PMSF and 0.1% and then extracted by boiling in Tris buffer, pH = 6.8, containing 2% SDS sulfate and 5% 2-mercaptoethanol. Eluates were electrophoresed on polyacrylamide gels as described (16).
Motility assays. PMN motility into micropore filters was assessed by a modified Boyden technique (7) . The distributions of cells within filters were evaluated with an Optomax Image Analyzer (Optomax, Inc., Hollis, NH) at various times after loading the chemotaxis chambers, and the depths at which only two cells were in focus in one high power (X 40) field were measured after incubation periods of 40-60 min (23) . Leukotactic indices were calculated as described (24).
Shape change assay. A modification of the method of Smith et al. (25) was utilized. Suspensions of PMNs were exposed to CFs under varying conditions and then fixed in cold (4°C) 1.5% glutaraldehyde. Fixed cells were examined with a X 1000 phase contrast objective and classified according to shape (25) .
Adherence assays. Adherence chambers were assembled as described (25) after pretreatment of one of two cover glasses for 2 min with a solution of 6% pooled human serum in DPBS. Each chamber was filled with a suspension of PMNs (5 X 105/ml), which was allowed to settle onto the pretreated glass substrate undisturbed at 21°C for 500 s. Chambers were then inverted for an additional 400 s. Cells remaining attached to the substrate surface were counted in 15-20 high power (x 400) fields. Chambers were again inverted and cells adhering to the untreated glass surface were counted. Results were expressed as the percentage of PMNs adhering to the treated surface over the total number of cells counted (treated plus untreated surfaces). A previously described albumincoated latex bead (ACLB) binding assay was also employed to quantitate adherence and to assess the distribution of PMN adhesion sites (26) .
Aggregometry. PMN aggregation was evaluated as described by Hammerschmidt et al. (27) . In most experiments, PMNs were preincubated with cytochalasin B (5 jsg/ml, 15 min, 37°C). After 30 s of stirring, f-Met-Leu-Phe, A23187, or zymosan-activated plasma (ZAP) was added to PMN suspensions (0.5 ml, I07 PMN/ml). PMN aggregate formation was confirmed by phase microscopy.
Spreading. The capacity of PMNs to anchor on plastic, glass, or HSA-anti-HSA-coated glass substrates was assayed as described (2, 3) . Cells attached to these substrates were fixed in 2% glutaraldehyde and evaluated by phase-contrast or scanning electron microscopy. Orientation in chemotactic gradients. Orientation chambers as described by Zigmond (28) were employed. PMN were allowed to attach to the center of glass cover slips pretreated with 5% HSA for 10 min at 21°C before they were inverted over the chamber bridge. Adjacent wells were loaded with solutions of CFs or DPBS. Cells overlying the bridge were observed with a x 40 phase objective between 30 and 60 min after loading the chamber wells with CFs. Degranulation. To determine lysosomal granule protein content and release after stimulation, untreated PMNs (107/ml) or PMNs pretreated with cytochalasin B (5 g/ml, 5 min, 37°C) were stimulated in a shaking water bath with f-Met-Leu-Phe (20 nM), PMA (10 g/ml), or opsonized zymosan, and then centrifuged at 400 g for 5 min at 4°C (29). The cellfree supernatant fluids or cell pellets were then assayed for lysozyme (30) , beta glucuronidase (31), lactoferrin (10) , and the cytoplasmic enzyme, lactic acid dehydrogenase (32) . Enzyme activities were expressed as a percentage of the total cell content released by stimulation as well as the total cell content of each enzyme.
Oxidative metabolic activity. Superoxide generation ofPMNs exposed to PMA was quantitated employing a ferricytochrome c reduction assay (33) . The evolution of CL by PMNs before or after metabolic activation by f-Met-Leu-Phe, A23187, PMA, or opsonized zymosan particles was quantitated as previously described (34) .
Phagocytosis assays. Phagocytosis of C3 or IgG opsonized emulsified paraffin oil droplets was measured as described by Stossel (35, 36) . For selective C3 opsonization, serum obtained from a patient with severe combined immunodeficiency disease was utilized. Uptake of ["4C]S.
aureus 502A was assayed as previously described (37). The rate ofuptake of zymosan was calculated from the slope of CL evolution as previously described (34) . Phagocytic ingestion of IgG opsonized ACLB (0.8 Mm) was evaluated in a similar CL assay. For these experiments, latex beads were exposed to 3% HSA for 2 min, washed three times, and then exposed to a 1:10 dilution of rabbit anti-HSA (30 min, 21°C).
Distribution ofFc receptors. Latex beads (0.8 um) were exposed to 3% HSA for 2 min, washed three times, and then exposed to a 1:10 dilution of rabbit anti-HSA (30 min, 21°C). PMNs prestimulated with 1 nM f-Met-Leu-Phe for 5 min at 37°C were then exposed to a 1% suspension of HSA-anti-HSA-coated latex beads containing 1 nM f-Met-Leu-Phe for 10, 20, or 90 s prior to fixation in 1.5% glutarldehyde. Bead binding distributions were identified by phase-contrast microscopy. HSA-coated latex beads exposed to anti-C3 and beads treated only with HSA demonstrated no binding.
Rosetting assays. Sheep erythrocytes (E) were coated with rabbit IgG anti-E (EIgG), C3b (EAC3b), or C3bi (EAC3bi) as previously described in detail (4, 38) . PMNs were kept at 4 X 106/ml in DPBS containing calcium and magnesium, 2 mg/ml bovine serum albumin, and I mg/ml soybean trypsin inhibitor (Millipore Corp., Bedford, MA). Cells (25 Ml) were incubated with 15 Ml of indicator sheep erythrocytes (1.5 x 108/ml) in 1.5-ml Eppendorf tubes, and the mixture was incubated in a water bath for 40 min at 37°C. To assess rosette formation, cells were gently resuspended and examined using a hemocytometer. Binding of three or more sheep erythrocytes to a PMN was considered a rosette (4).
Antibody-dependent cellular cytotoxicity (ADCC). ADCC to herpes simplex virus (HSV)-infected 51Cr-labeled Chang liver target cells was assessed as previously described (39, 40) . PMNs were diluted to yield effector-to-target cell ratios of 30:1-100:1 in an 18-h cytotoxicity assay with a final anti-HSV human immune or nonimmune serum concentration of 1:20. A single cell agarose assay was also performed as described by Silva et al. (41) . Unlabeled HSV-infected Chang liver target cells (2 x l0 cells/100 Ml) were incubated with PMNs (1:1, effector-to-target cell ratio). Slides of these mixtures were prepared using 1.0% agarose.
After an 18-h incubation, these were stained with trypan blue and fixed in 0.5% formalin. For each coded slide assessed, 200 PMNs were counted to determine the number of PMNs binding to target cells and the percent of those which killed target cells (trypan blue exclusion).
Tubulin immunofluorescence (IF) and concanavalin-A capping procedure. PMNs were processed for quantitation of cytoplasmic microtubules (MT) as previously described by Anderson et al. (42) . Distributions of FITC-concanavalin A binding were assessed for both unstimulated PMN suspensions and those pretreated with colchicine or CF before their exposure to FITC-concanavalin A (15 ug/ml, 10 min at 37°C) (43).
f-Met-Leu-3H-Phe binding. PMNs (108/ml), f-Met-Leu-3H-Phe, and cold f-Met-Leu-Phe were incubated in 200 IA of DPBS at 00 or 37°C as described (7). Reactions were terminated by rapid dilution in cold (4°C) DPBS followed by filtration and washing (5 ml, twice) of mixtures through Whatman GFC filters (Whatman Laboratory Products, Inc., Clifton, NJ). Filters were placed into 10 ml Fluorosol Scintillation Cocktail (National Diagnostics, Inc., Somerville, NJ) and radioactivity was quantitated in a Packard Tri-Carb liquid scintillation spectrometer (Packard Instrument Co., Downers Grove, IL). Specific binding was defined as the total amount of f-Met-Leu-3H-Phe minus that proportion nonspecifically bound (7).
Membranefluidity and surface charge. Membrane fluidity of PMNs (3 X 108/ml) was measured at 37°C using a Bruker ER-200D electron spin-resonance spectrometer equipped with a computer for signal averaging (USA Bruker Instruments, Inc., Billerica, MA), and 40 MM 5-doxyl stearic acid (Molecular Probes, Inc., Junction City, OR) as described (44) . PMNs were stimulated with DPBS or 10 nM f-Met-Leu-Phe for 10 min and the order parameter (S), a measurement of spin label order and motion, was calculated (44) . Cell surface charge was measured as described (45) using a microscope-monitored calibrated electrophoresis apparatus (Grant Instruments Ltd., Cambridge, England). PMNs (5 x 106 PMN/ml) were incubated for 10 min with PBS or with f-MetLeu-Phe (10 nM) plus cytochalasin B (10 M). Cell mobility (Am) was calculated as described for at least 20 cells of each suspension and the results were reported as micrometers per second per volt per centimeter (45) .
Scanning electron microscopy. PMNs were fixed in a solution of 1.5% glutaraldehyde in DPBS for 1 h, washed three times, and then dehydrated by a graded series of acetone washes. After drying in a Bowmar critical point drying apparatus (Bowmar Instrument Corp., Ft. Wayne, IN), samples were sputter coated with 8 nm gold palladium with a Denton Disk-l apparatus (Denton Vacuum, Inc., Cherry Hill, NJ) and examined with a JEOL 100 CX electron microscope operating at 15 kV (JEOL USA, Electron Optics Division, Medford, MA) (7). A small but detectable increase in molecular weight was noted at each acrylamide concentration after reduction with 2-mercaptoethanol and the length of gels and total time of electrophoresis experiments caused additional variations in the estimates of molecular weight.
Results

SDS-PAGE. Results of SDS-PAGE
Labeling of surface glycoproteins. To confirm that the deficient protein was expressed on the cell surface, surface glycoproteins were labeled with NaB3H4 after neuraminidase treatment and oxidation with galactose oxidase (18) (Fig. 2) . A major surface glycoprotein or protein complex was extremely deficient or totally absent in the patient's PMNs. Although some qual- Figure 2 . Surface labeling of healthy adult and GP138-deficient PMNs. PMNs from a healthy adult control and the patient were labeled with NaB3H4 and processed in SDS-PAGE. Patient PMNs demonstrate a severe deficiency of high molecular weight glycoprotein(s) (fractions 5-8). The apparent molecular weight of the deficient protein detected under these conditions is 165 kD. DPM, decays per minute.
itative differences of the various labeled peaks were observed, the major peak of activity in each of eight adult or age-matched controls (1 1.5±7.2% of total protein labeling) was identified in fractions 5-8. Significantly reduced labeling of maternal cells was also observed (data not shown). Employing 7% gels, the apparent molecular weight of the labeled protein was 165 kD. However, identical gels stained with Coomassie Blue G indicated that the deficient protein had a molecular weight of 145 kD. An explanation for this difference is uncertain, although it appeared to be unrelated to neuraminidase treatment.
Although increased proteolytic activity in the patient's cells or increased susceptibility to proteolysis by the patient's surface proteins cannot be rigorously excluded by these experiments, mixing of the patient's cells with normal cells did not decrease the amount of deficient protein added.
Analysis of cell surface antigens by flow cytometry immunofluorescence. As shown in Fig. 3 Fig. 4 illustrates results for f-Met-Leu-Phe experiments. With respect to both C5a and f-Met-Leu-Phe, comparable threshold concentrations (CSa, 1.2 Ag/ml; f-Met-Leu-Phe, 0.1 nM) effected cell activation (membrane ruffling) of patient and control PMNs (24). At maximally effective concentrations (C5a; 4 ,g/ml, f-Met-Leu-Phe; 2 nM), the percent of patient PMNs demonstrating bipolar morphology was comparable with that of control cells (Fig. 4 A) . In kinetic experiments, patient PMNs demonstrated normal bipolar shape change at all time intervals between 20 and 60 s after exposure to 2 nM f-Met-Leu-Phe (data not shown) and demonstrated normal uropod formation under all test conditions (Fig. 4 B) .
Specific binding off-Met-Leu-3H-Phe. In contrast, the distribution ofACLB binding sites ofpatient PMNs was essentially normal; they demonstrated a normal capacity to redistribute their "adhesion sites" to the cell uropod following sequential f-Met-Leu-Phe stimulation (patient, 55±14%; healthy adult, 62±12%; mother, 50±8%; father, 63±11%). Thus, impaired enhancement ofpatient cell adherence by chemotactic or secretory stimuli reflects a limited capacity to initiate new "adhesion sites" in response to these stimuli. A failure of sequential chemotactic stimuli to diminish their adherence would appear to reflect a diminished number of "adhesion sites" rather than an inability to laterally redistribute them to the cell uropod. Aggregometry. Studies shown in Fig. 6 demonstrate a significantly (P < 0.001) diminished capacity of patient PMNs to aggregate when exposed to CFs, PMA, or A23187. As shown by immunofluorescence microscopy, a failure of the patient's cells to adhere to one another but not to control PMNs was confirmed by employing test mixtures of control PMNs and FITC-stained patient PMNs. Mean±SD values (in ZAP units) for CF-stimulated patient cells (f-Met-Leu-Phe, 28±7; ZAP, 35±9) were significantly (P < 0.00 1) diminished compared with values for maternal (f-Met-Leu-Phe, 84±12; ZAP, 110±10), or healthy adult control (f-Met-Leu-Phe, 79±14; ZAP, 100±0) suspensions. In response to PMA (10 ug/ml) or A23187 (MM), diminished aggregation by patient (P < 0.001) and maternal (P < 0.05) suspensions as compared with healthy adult control suspensions was also observed. Cell spreading (anchorage). Anchorage of patient cells to either glass or plastic substrates was severely diminished as compared with healthy adult, maternal, or age-matched controls (Table I) An apparent discrepancy between findings of normal shape change by patient cells in suspension (Fig. 4) and impaired orientation while attached to surfaces was carefully evaluated with scanning electron micrographs of patient cells fixed while undergoing orientation in Zigmond chambers (Fig. 8) . As shown, adherent patient cells were clearly activated (bipolar) in a plane perpendicular to the substrate after exposure to CFs (Fig. 8 D) , but they were unable to initiate lateral or peripheral areas of attachment with the substrate (Fig. 8 E) .
Degranulation. Studies of patient cell secretion in response to stimulation with CFs or PMA and "regurgitation" during phagocytosis of zymosan particles are summarized in Table III Table IV demonstrate considerable heterogenity of phagocytosis by GP138-deficient PMNs with respect to the test particle employed. Findings of diminished uptake by patient cells of radiolabeled staphylococcal organisms or zymosan confirmed previous findings for these test particles (6) . Their uptake of Oil-Red-0-paraffin emulsions selectively opsonized with C3-derived ligands was also significantly (P < 0.01) diminished compared with healthy adult or maternal controls, but their uptake of IgG opsonized Oil-Red-0 emulsions was only slightly diminished compared with that of control suspensions (P > 0.05). As assessed with a phagocytosis-associated CL assay, their rate of uptake and/or binding of IgG opsonized ACLB was significantly (P < 0.01) enhanced as compared with adult controls.
Studies ofphagocytic ingestion. Results in
These findings suggested that abnormalities of ingestion were related to functional abnormalities of the C3b receptor complex, but not membrane Fc receptors. Therefore, rosette assays employing sensitizied sheep erythrocytes were performed as summarized in Table V (B) f-Met-Leu-Phe (uM), or (C) A23187 (MM) are illustrated. As confirmed by phase-contrast microscopy, aggregates in patient suspensions were profoundly diminished or absent.
sequentially ingested and redistributed posterially (normally) toward the cell nucleus. As compared with control PMNs, normal binding distributions and normal kinetics of"Fc-facilitated" ingestion by patient cells were observed at 10, 30, and 90 s after exposure to anti-HSA-ACLB (data not shown). Finally, normal Fc receptor binding by GP138 deficient PMNs was shown by the additional findings that their impaired capacity to spread was normalized when exposed to HSA-anti HSA, but not HSAanti HSA F(ab')2, coated glass substrates. Scanning electron micrographs shown in Fig. 9 demonstrate normal "Fc-facilitated" spreading by representative patient PMNs.
ADCC. The patient's PMNs were essentially nonreactive in ADCC at effector-to-target cell ratios from 100:1 to 30:1 (Table  VI) . The patient's mother had ADCC values similar to that of a normal adult control. To evaluate the role of cell adhesion with respect to this cytotoxic defect, an agarose single cell cytotoxicity assay was utilized. In this assay, 5 to 6% of maternal and adult control PMNs bound to target cells in the presence of antibody, in contrast to only 0.5% of the patient's cells (P < 0.001). So few target cells were bound by patient PMNs that calculation of the percent killed (50±70%) was considered to be unreliable.
Characterization ofcytoplasmic MTs. Quantitative or functional assessment of MTs of patients cells were performed employing tubulin IF (42) . Because cells were easily detached from substrates during this procedure, cytocentrifugation was required to insure attachment to glass substrates. Both the mean number of MTs per cell (patient, 31.9±4.0; healthy adult, 34.8±4. 59 .7±12.1). These findings indicate that diminished oxidative activity of patient PMNs during phagocytosis (Table IV) reflects abnormalities of cell-particle interactions rather than intrinsic abnormalities of the respiratory apparatus.
Membrane fluidity and cell sur,face charge. In further assessments of the biophysical properties of the patient's PMN membranes, the spin label 5-doxyl stearic acid and electron spin resonance spectroscopy were used to measure membrane fluidity. The order parameters (S) of unstimulated control and patient PMNs at 37°C were equivalent (S = 0.637 vs. 0.637). In addition, f-Met-Leu-Phe (1O nM) stimulated changes in membrane fluidity of patient PMNs were comparable with adult control PMNs (patient, S = 0.648±0.0014; healthy adult, S = 0.649±0.0014; P > 0.05).
The mean cell mobilities of healthy adult, patient, or maternal PMNs incubated with PBS were 2.72, 2.73, and 2.70, respectively. Similarly, the cell mobilities of PMNs stimulated above (or below) during orientation experiments. Frame (C) shows a cell similar to that represented in (B) as visualized in a plane perpendicular to the substrate to which the cell is attached. The same sequence is shown for patient PMNs (D-F). Normal bipolar shape change of attached patient cells does occur (F) but only in the plane perpendicular to the glass substrate (A-E, X 2,325; F, X 4,300).
with f-Met-Leu-Phe were essentially identical among these three donors.
Discussion
The critical role of cell adherence in allowing expression of normal PMN functions and the pathogenic importance of adhesive abnormalities in clinical disorders of PMN function have been increasingly recognized (1-7, 25, 26, 28, 29, 34, 50-53) . Molecular events contributing to adherence are incompletely understood, but studies employing time lapse photography or photomicrography have shown that PMNs adhere preferentially to vascular endothelium adjacent to a site ofinflammation before their migration into tissues (54) . This directed adherence is facilitated by the occupancy of membrane receptors by C5a and other biproducts of inflammation which elicit a sequence of effects or mechanisms that enhance cellular adherence (25, 26, 50, (55) (56) (57) . The identification in this case and in previous in- (60) . In addition, both CTL-target cell adherence (61) and adherence through the CR3 (62, 63) are dependent on divalent cations. In contrast, adherence mediated by CR1 and Fc receptors (both normal in our patient) are divalent cation-independent (64) . Precise comparisons between our patient and those in previous studies have been limited due to the convention of reporting estimates ofthe molecular weight ofPMN glycoproteins as determined by SDS-PAGE (2) (3) (4) (5) . Depending on the conditions of SDS-PAGE in this study, estimates of the molecular weight of the deficient glycoprotein ranged from 138 to 229 kD. SDS does not bind to proteins with large sugar content as efficiently as to other proteins, thus accounting for an anomolous behavior of glycoproteins in SDS-PAGE systems (65, 66) . Considering these limitations, the use of specific MAb to surface antigens will be required to compare patients with leukocyte glycoprotein deficiency syndromes.
The collaborative use of MAbs to Mol and LFA1 has confirmed that our patient (GP138 deficiency) represents an example of an identical or very similar disorder (GP150 deficiency) previously described by Arnaout et al. (4, 5) . Differences between the functional capabilities ofGP1 50-deficient as compared with GP138-deficient PMNs may be explained by quantitative differences ofMol deficiency among these two patients. Scatchard analyses of '25I-F(ab')2 anti-Mo 1 binding data revealed that the previously reported male patient (4, 5) had 7,000±3,000 Mol sites/cell as compared with 0 sites/cell in our patient, and 65,000±7,000 sites/cell for normal controls. Studies in another male patient with GP1 38 deficiency indicate diminished (e10% of normal) but not totally deficient PMN OKM 1 (67) . Our patients and those previously described in detail by Crowley et al. (2) , Bowen Abnormalities of PMN adherence and associated deficits of chemotaxis have been previously recognized in other clinicopathologic models demonstrating impaired inflammation and enhanced susceptibility to microbial invasion (2-7, 23, 28, 50-54) . Abnormal neutrophil adherence, aggregation, and chemotaxis in vitro associated with a heritable deficiency of specific granule lactoferrin has been well described in two patients (29, 51) . In one case, the incubation of purified neutrophil lactoferrin with patient cells permitted them to adhere normally, suggesting that diminished lactoferrin secretion was responsible for complex defects of membrane associated cell function, including abnormalities of cell surface charge. Our patient's cells demonstrated normal surface charge, normal specific granule morphology (transmission EM), and normal secretion of lactoferrin in response to CFs or secretagogues. The extent of lactoferrin release by Mol/LFA 1-deficient PMNs in vivo while adhering to endothelial cells (margination) or during inflammation remains to be determined.
Elevated adherence associated with abnormalities of neutrophil motility and cyclic nucleotide metabolism was reported in a female patient with recurrent soft tissue infections (52) . Excessive MT assembly was observed in that patient's cells in contrast with our findings. Mol/LFAl does not appear to be required for polymerization or depolymerization of MTs per se. However, since adherence itself promotes MT assembly in normal PMNs, deficiency of Mol/LFA 1 may indirectly impair MT function (42) .
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